NOXXON PHARMA NV (ALNOX.PA) Stock Cash Flow
Europe - Euronext Paris - EPA:ALNOX - NL0012044762 - Common Stock
0.041 EUR
-0.01 (-18%)
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.45M | -10.41M | -860.00K | -10.74M | -5.39M | |||
| Depreciation Amortization | 70.00K | 60.00K | 50.00K | 20.00K | 29.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 410.00K | 360.00K | -370.00K | 320.00K | 65.00K | |||
| Interest Paid | 2.00K | 3.00K | 3.00K | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.60M | 4.76M | -3.10M | 6.39M | 1.06M | |||
| OPERATING CASH FLOW | -12.38M | -5.22M | -4.29M | -4.00M | -4.24M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -10.00K | -40.00K | -20.00K | -10.00K | -2.00K | |||
| Other Investing Activity | 0.00 | 0.00 | 0.00 | 70.00K | 126.00K | |||
| INVESTING CASH FLOW | -10.00K | -40.00K | -20.00K | 70.00K | 124.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 4.35M | 5.69M | -30.00K | 3.35M | 1.86M | |||
| Stock Issued/Repurchased | 7.22M | 8.79M | 1.52M | 4.41M | 854.00K | |||
| Other Financing Activity | -70.00K | -300.00K | -100.00K | -160.00K | -193.00K | |||
| FINANCING CASH FLOW | 11.50M | 14.18M | 1.40M | 7.60M | 2.52M | |||
| Exchange Rate Effect | 50.00K | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -840.00K | 8.92M | -2.91M | 3.67M | -1.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.38M | -5.22M | -4.29M | -4.00M | -4.24M | |||
| Capital Expenditure | -10.00K | -40.00K | -20.00K | -10.00K | -2.00K | |||
| FREE CASH FLOW | -12.39M | -5.26M | -4.31M | -4.01M | -4.24M | |||
All data in EUR